Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Reaches New 1-Year High - Here's Why

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) reached a new 52-week high on Wednesday . The company traded as high as $8.99 and last traded at $8.90, with a volume of 10882 shares trading hands. The stock had previously closed at $8.84.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

The company has a market cap of $14.72 billion, a price-to-earnings ratio of 14.74, a P/E/G ratio of 1.99 and a beta of 0.21. The company has a current ratio of 6.63, a quick ratio of 6.13 and a debt-to-equity ratio of 0.01. The stock has a 50 day moving average price of $8.34 and a two-hundred day moving average price of $7.74.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.03). The company had revenue of $721.77 million during the quarter, compared to analyst estimates of $824.23 million. Analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.